The states consider it a move to force the F.D.A. to review and acknowledge extensive research showing the pill’s safety.
Category: Drugs (Pharmaceuticals)
-
Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatments
The U.S. health secretary said people should have access to experimental therapies including unregulated stem cells. But some methods have resulted in blindness, tumors and other injuries.
-
On the Campaign Trail, Elon Musk Juggled Drugs and Family Drama
As Mr. Musk entered President Trump’s orbit, his private life grew increasingly tumultuous and his drug use was more intense than previously known.
-
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs
The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.
-
Benzo Withdrawal Symptoms Can Be Life-Threatening
The drugs treat disorders such as anxiety, panic attacks and insomnia, but stopping them abruptly can compound users’ symptoms and even endanger their lives.
-
Trump Signs Executive Order Asking Companies to Lower Drug Prices
The president has long complained that the United States pays more for medicines than other wealthy countries. But he offered no clear legal authority to mandate lower prices.
-
Trump Plan Would Tie Some Drug Prices to What Peer Nations Pay
The president announced an executive order aimed at lowering U.S. drug costs, revisiting an idea that was blocked in court during his first term.
-
Trump Plan Would Tie Some Drug Prices to What Peer Nations Pay
The president announced an executive order aimed at lowering U.S. drug costs, revisiting an idea that was blocked in court during his first term.
-
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.
-
WeightWatchers Files for Bankruptcy to Reduce $1 Billion in Debt
The company, which has shaped how millions eat and exercise, is trying to reduce its debt as it expands its telehealth business.
-
Chinese Imports to US Hit 20-Year Low as Tariffs Sink In
While imports can swing with seasonal shifts, President Trump’s ratcheting up of U.S. tariffs on China has begun to cascade through supply chains, government data shows.
-
Kennedy Issues Demands for Vaccine Approvals that Could Affect Fall Covid Boosters
The agency suggested that clinical trials in humans may be required for updated Covid shots, raising questions about whether they will be available in the fall.